Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 8, 2012Company gains first and only commercially available subcutaneous ICD technology to offer lifesaving therapy to patients at risk of sudden cardiac arrest
Boston Scientific Corporation (NYSE: BSX) announces the exercise of its option to acquire Cameron Health, Inc., a privately held company based in San...
-
Mar 8, 2012
Boston Scientific Corporation (NYSE: BSX) and Lumenis, the market leader in holmium laser technology, announced the signing of a five-year contract...
-
Mar 1, 2012Next-generation coronary stent employs innovative alloy designed to improve acute performance
Boston Scientific Corporation (NYSE: BSX) announces the launch of the PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent System in...
-
Feb 23, 2012
Boston Scientific Corporation (NYSE: BSX) announces the first implants of a TELIGEN® implantable cardioverter defibrillator (ICD) in China. The...
-
Feb 22, 2012ION™ and TAXUS® Liberte® Paclitaxel-Eluting Stent Systems now approved for treating patients with acute myocardial infarction in the U.S.
Boston Scientific Corporation's (NYSE: BSX) ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System and TAXUS® Liberte® Paclitaxel-Eluting...
-
Feb 22, 2012
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2012 RBC Capital Markets' Global Healthcare Conference on February 29 in...
-
Feb 13, 2012
Boston Scientific Corporation (NYSE: BSX) announces that Moody's Investors Service has upgraded the Company's corporate credit rating to an investment...
-
Feb 8, 2012TruePath™ CTO Device designed to facilitate crossing of chronic total occlusions
Boston Scientific Corporation (NYSE: BSX) announces the U.S. launch of the TruePath™ CTO Device, designed to facilitate the crossing of chronic total...
-
Feb 7, 2012
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Leerink Swann 2012 Global Healthcare Conference on February 15 in New York....
-
Feb 7, 2012Studies published in peer-reviewed medical journals
Boston Scientific Corporation (NYSE: BSX) welcomes positive results from three studies of the WallFlex® Enteral Stent Systems, a family of...